The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Are enrollment criteria for phase II and III clinical trials in acute myeloid leukemia arbitrarily restrictive?
 
Andrew Hantel
No Relationships to Disclose
 
Thomas Walsh
No Relationships to Disclose
 
Dillon Clancy
No Relationships to Disclose
 
Marlise Rachael Luskin
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Abbvie (Inst); Novartis (Inst)
 
Daniel J. DeAngelo
Consulting or Advisory Role - Amgen; Blueprint Medicines; Gilead Sciences; Incyte; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Pfizer; takeda
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); glycomimetics (Inst); Novartis (Inst)
 
Christopher S. Lathan
Consulting or Advisory Role - Bristol Myers Squibb; Bristol Myers Squibb Foundation; Lilly; Lilly
 
Gregory A. Abel
Consulting or Advisory Role - Novartis